Armata Pharmaceuticals Statistics
Total Valuation
ARMP has a market cap or net worth of $166.67 million. The enterprise value is $535.59 million.
| Market Cap | 166.67M |
| Enterprise Value | 535.59M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARMP has 36.71 million shares outstanding. The number of shares has increased by 0.41% in one year.
| Current Share Class | 36.71M |
| Shares Outstanding | 36.71M |
| Shares Change (YoY) | +0.41% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 11.07% |
| Float | 11.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.04 |
| Forward PS | 120.34 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 102.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.64
| Current Ratio | 0.64 |
| Quick Ratio | 0.52 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -25.32% |
| Return on Invested Capital (ROIC) | -27.82% |
| Return on Capital Employed (ROCE) | -61.46% |
| Weighted Average Cost of Capital (WACC) | 6.18% |
| Revenue Per Employee | $85,279 |
| Profits Per Employee | -$4.63M |
| Employee Count | 61 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +89.17% in the last 52 weeks. The beta is 1.27, so ARMP's price volatility has been higher than the market average.
| Beta (5Y) | 1.27 |
| 52-Week Price Change | +89.17% |
| 50-Day Moving Average | 6.31 |
| 200-Day Moving Average | 7.55 |
| Relative Strength Index (RSI) | 40.43 |
| Average Volume (20 Days) | 167,677 |
Short Selling Information
The latest short interest is 704,657, so 1.92% of the outstanding shares have been sold short.
| Short Interest | 704,657 |
| Short Previous Month | 206,873 |
| Short % of Shares Out | 1.92% |
| Short % of Float | 6.16% |
| Short Ratio (days to cover) | 3.20 |
Income Statement
In the last 12 months, ARMP had revenue of $5.20 million and -$282.61 million in losses. Loss per share was -$7.78.
| Revenue | 5.20M |
| Gross Profit | -11.20M |
| Operating Income | -31.82M |
| Pretax Income | -282.61M |
| Net Income | -282.61M |
| EBITDA | -35.62M |
| EBIT | -37.23M |
| Loss Per Share | -$7.78 |
Balance Sheet
The company has $4.75 million in cash and $373.67 million in debt, with a net cash position of -$368.92 million or -$10.05 per share.
| Cash & Cash Equivalents | 4.75M |
| Total Debt | 373.67M |
| Net Cash | -368.92M |
| Net Cash Per Share | -$10.05 |
| Equity (Book Value) | -311.59M |
| Book Value Per Share | -8.50 |
| Working Capital | -3.28M |
Cash Flow
In the last 12 months, operating cash flow was -$23.97 million and capital expenditures -$506,000, giving a free cash flow of -$24.47 million.
| Operating Cash Flow | -23.97M |
| Capital Expenditures | -506,000 |
| Depreciation & Amortization | 1.61M |
| Net Borrowing | 15.00M |
| Free Cash Flow | -24.47M |
| FCF Per Share | -$0.67 |
Margins
| Gross Margin | -215.24% |
| Operating Margin | -611.61% |
| Pretax Margin | -5,432.80% |
| Profit Margin | n/a |
| EBITDA Margin | -684.68% |
| EBIT Margin | -715.65% |
| FCF Margin | n/a |
Dividends & Yields
ARMP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.41% |
| Shareholder Yield | -0.41% |
| Earnings Yield | -169.57% |
| FCF Yield | -14.68% |
Analyst Forecast
The average price target for ARMP is $17.50, which is 285.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.50 |
| Price Target Difference | 285.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARMP has an Altman Z-Score of -13.6 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.6 |
| Piotroski F-Score | 4 |